R-Pharm Overseas, Inc. clinical trials
A country office of R-Pharm
The registry lists 3 studies whose lead sponsor is R-Pharm Overseas, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 15, 2024.
Registry sponsor names on this page
- R-Pharm Overseas, Inc.3 studies
Something wrong with this grouping? Tell us on the R-Pharm page.
Studies
Recruiting first, then most recently updated. Showing 3 of 3. All R-Pharm studies →
- Study of the Efficacy and Safety of RPH-104 in Adult Subjects With Schnitzler SyndromeWithdrawnNCT04213274Phase 2
Sponsor listed in the registry: R-Pharm Overseas, Inc.
- Efficacy and Safety of RPH-104 Treatment in Patients With Recurrent PericarditisSuspendedNCT05107934Phase 2/3
Sponsor listed in the registry: R-Pharm Overseas, Inc.
- Study to Evaluate the Effect on Parameters of Systemic Inflammation and Disease Outcomes and Safety of RPH-104 in Subjects With Acute ST-elevation Myocardial InfarctionCompletedNCT04463251Phase 2
Sponsor listed in the registry: R-Pharm Overseas, Inc.